Ibrutinib-associated pityriasis rosea–like rash
نویسندگان
چکیده
منابع مشابه
Ibrutinib-associated pityriasis rosea–like rash
CLL: chronic lymphocytic leukemia PR: pityriasis rosea EGFR: epidermal growth factor receptor PDGFR: platelet-derived growth factor receptor I brutinib, a Bruton tyrosine kinase inhibitor, is a new oral agent approved for the treatment of chronic lymphocytic leukemia (CLL). Ibrutinib is well-tolerated, with the majority of its adverse events within grade 1 or 2 severity. The most common nonhema...
متن کاملRash Associated with Ibrutinib Therapy for Chronic Lymphocytic Leukemia
Ibrutinib is used in the treatment of chronic myeloid leukemia. While patients taking the drug have developed rashes, there are few case reports and studies documenting this adverse effect. We present a case of rash associated with Ibrutinib therapy in a patient with chronic lymphocytic leukemia.
متن کاملGlucagonoma-Associated Rash.
A 65-year-old man with type 2 diabetes and deterioration of glycemic control presented with a 2-to-3-month history of weight loss (7 to 8 kg), early satiety, and mild flank pain. Before the occurrence of these symptoms, a rash had developed over the course of 3 to 4 weeks. The rash involved the arms, genitals, and buttocks and had progressed to the legs (Panel A). Laboratory evaluation at prese...
متن کاملDermatomyositis associated with Pityriasis Rubra Pilaris: A case report
A 9-year old boy had severe muscle weakness and typical skin rash and EMG with diagnosis of dermatomyositis associated with erythrodermia with islands of normal skin and palmoplantar hyperkeratosis, which was reported. As PRP in skin biopsy. Association dermatomyositis with PRP is very rare.
متن کاملPityriasis Rosea-Like Rash Secondary to Intravesical Bacillus Calmette-Guerin Immunotherapy
Received March 11, 2011, Revised August 29, 2011, Accepted for publication August 30, 2011 Corresponding author: Chi Yeon Kim, M.D., Ph.D., Department of Dermatology, Gyeongsang National University Hospital, 79 Gangnam-ro, Jinju 660-702, Korea. Tel: 82-55-750-8184, Fax: 82-55-7588106, E-mail: [email protected] This is an Open Access article distributed under the terms of the Creative Commons...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: JAAD Case Reports
سال: 2018
ISSN: 2352-5126
DOI: 10.1016/j.jdcr.2017.06.035